Viewing Study NCT07225504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2026-01-24 @ 5:29 AM
Study NCT ID: NCT07225504
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-11-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary Progressive Multiple Sclerosis (SPMS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MS View
None Multiple sclerosis View
None secondary progressive multiple sclerosis View
None SPMS View
None remibrutinib View
None LOU064 View
None adult View
None Expanded Disability Status Scale View
None EDSS View
None McDonald diagnostic criteria View